Supplement Sales Down in Mass for Fiscal 2000Supplement Sales Down in Mass for Fiscal 2000
March 5, 2001
CHICAGO--According to a report released by the sales-tracking organization Information Resources Inc. (IRI), in the year ended Jan. 28 for fiscal 2000, dietary supplement sales in mainstream stores were down for herbal supplements and vitamins, but up for multi-vitamins and minerals. IRI compiled data for vitamins, minerals and supplements through sales via supermarkets, drug stores and mass merchandisers. The report excluded sports nutrition and diet products.
Taking into consideration all categories, the entire supplement industry was down 3.0 percent. Total sales of herbal supplements were down 15.8 percent and sales for vitamins were down 4.3 percent, whereas sales for multi-vitamins and minerals were up 2.3 and 1.3 percent, respectively. Those supplements experiencing some of the biggest sales deficits included cat's claw (-50.6 percent), eyebright (-55.9 percent) and yucca (-59.3 percent). The most impressive supplement sales gains included guarana, (40.9 percent), green tea (42.4 percent), valerian (78.9 percent), and soy (90.2 percent). In vitamin sales, the only sales increase was for vitamin K, which experienced a 16.1 percent increase over 1999 sales to bring total dollar sales to $10,554. The largest sales deficit over last year was had by vitamin C, with a decrease of -19.2 percent and 2000 sales of approximately $190 million.
Not all supplements were on the downtrend. In the realm of multivitamins, children's vitamins experienced a 7.5-percent increase in sales, while adult multivitamins had a 1.8-percent increase in sales. In terms of brand-name multivitamins, geriatric-minded Centrum Silver multivitamin sales went up 13.2 percent to approximately $120 million for 2000. However, this affected the sales of one of its main competitors, Geritol Complete, which raked in -9.4 percent less compared to the year prior.
According to Gregory Badishkanian at Saloman, Smith & Barney, the supplement sector may remain in a difficult cycle until at least the third quarter this year. Of course, the prosperity of the industry depends on the introduction of hot new products or substantially positive media reports. In the meantime, he recommended "that investors wait another two quarters before entering--or increasing their positions within--the nutritional supplement space." For more information, visit www.infores.com.
You May Also Like
Sep 28, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023
The ashwagandha root production process: Where tradition meets science – article part threeSep 21, 2023